In 2021, the proportion of patients with a confirmed diagnosis of CHF in the patient cohort admitted to a cardiology hospital was twice as high as in 2002; the phenotype with preserved left ventricular ejection fraction predominated in the CHF structure. During the analyzed twenty-year period, the prevalence of comorbidities increased among CHF patients. The prescription frequency of pathogenetic evidence-based therapy has significantly increased by 2021, however, it remains insufficient even in patients with CHF with reduced left ventricular ejection fraction.
Keyphrases
- ejection fraction
- aortic stenosis
- left ventricular
- heart failure
- end stage renal disease
- risk factors
- healthcare
- prognostic factors
- acute myocardial infarction
- case report
- atrial fibrillation
- bone marrow
- acute kidney injury
- acute coronary syndrome
- emergency department
- hypertrophic cardiomyopathy
- left atrial
- adverse drug